ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ALHC vs CSTL // DIVIDEND YIELD & FCF PAYOUT SAFETY

Alignment Healthcare Inc. (NASDAQ) VS. Castle Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: ALHC 6 — CSTL 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALHC VS. CSTL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ALHC CSTL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 79.40% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 13.90% -9.30% +23.20 ALHC /roic <GO>
EV/EBITDA & P/E Valuation 37.8x — — TIE /valuation <GO>
Free Cash Flow Yield 6.77% 2.41% +4.36 ALHC /fcf-yield <GO>
Operating Margin 0.40% -12.40% +12.80 ALHC /operating-margins <GO>
Net Profit Margin 0.00% -7.00% +7.00 ALHC /net-margins <GO>
Revenue Growth (YoY) 46.10% 3.70% +42.40 ALHC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety ACTIVE 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.00 6.97 -2.97 CSTL /balance-sheet <GO>
Piotroski F-Score Quality 6/9 6/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.6 60.9 -29.24 CSTL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.67B $1.18B $495.5M ALHC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ALHC REV CSTL REV ALHC GROSS % CSTL GROSS % ALHC FCF CSTL FCF
FY 2025 $3.95B $344.2M — 79.4% $113.1M $28.3M
FY 2024 $2.70B $332.1M — 81.9% -$6.6M $36.5M
FY 2023 $1.80B $219.8M — — -$59.2M -$5.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALHC // BETA —
CSTL // BETA —